We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




U.S. Expands BSE Testing Program in Cows

By HospiMedica staff writers
Posted on 30 Mar 2004
Following an identified U.S. More...
case of mad cow disease, or bovine spongiform encephalopathy (BSE), the U.S. Department of Agriculture (USDA, Washington, DC, USA) has announced an expansion in its program of testing cows.

The USDA plans to test approximately 400,000 cows over the next 12-18 months and has licensed the rapid BSE test of Bio-Rad Laboratories, Inc. (Hercules, CA, USA; www.bio-rad.com). Called TeSeE, the test is for use by the U.S. National Veterinary Service Laboratories (Ames, IA, USA), which will do the actual testing.

"We are pleased that our test has met the stringent requirements of the USDA qualification process,” remarked Brad Crutchfield, vice president of Life Science at Bio-Rad. "Bio-Rad has extensive experience working with more than 500 labs in 25 countries around the world that screen for BSE.”

Bio-Rad's test detects the presence of the resistant form of prion protein, or PrPres, linked to BSE and can identify these prions at extremely low levels. The capability to detect very low levels of prions helps ensure that BSE-infected animals do not go undetected. The BSE test is also the easiest testing method to adapt to mass screening programs, according to the company. The test runs on an automated robotics platform and can produce results in just four hours, or can process up to 1,000 samples in eight hours.

"The test's speed, ease-of-use, high degree of sensitivity and accuracy have placed it in the highest scientific regard and will aid in the USDA's efforts to conduct a reliable and highly effective surveillance program,” added Mr. Crutchfield.

Bio-Rad is the leading provider of tests for detecting diseases in the field of transmissible spongiform encephalopathies (TSEs), having provided more than 22 million BSE tests to laboratories throughout Europe and Japan. The company also supplies tests for other TSEs, including chronic wasting disease (CWD), found in deer and elk.

"In Colorado, we have tested nearly 47,000 deer and elk in the last 18 months using Bio-Rad's CWD test,” said Dr. Barbara Powers, director of Colorado State University's Veterinary Diagnostic Laboratory, who worked closely with the Colorado Division of Wildlife on the 2002 field validation studies of Bio-Rad's CWD test. "The test has proven to be extremely accurate, fast, very easy to perform, and it is also efficient and cost effective,” Dr. Powers added.




Related Links:
Bio-Rad
USDA

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Exam Table
PF400
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.